MSTN and Duchenne muscular dystrophy: While mdx mice have lower serum MSTN levels (~ 50 ng/ml) than their wild-type counterparts, their concentration is much higher and proportionally less diminished compared to humans affected by DMD (~ 1 ng/ml), potentially providing a greater scope for the effects of MSTN inhibition [105].